Mon, January 22, 2024

Josh Schimmer Reiterated (BBIO) at Buy and Held Target at $50 on, Jan 22nd, 2024

Josh Schimmer of Cantor Fitzgerald, Reiterated "BridgeBio Pharma, Inc." (BBIO) at Buy and Held Target at $50 on, Jan 22nd, 2024.

Josh has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Josh's Rating of Hold.



This is the rating of the analyst that currently disagrees with Josh


  • David Lebowitz of "Citigroup" Initiated at Strong Buy and Held Target at $42 on, Tuesday, November 7th, 2023